Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration.

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from Novavax.

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

An FDA committee will soon make recommendations about this fall’s Covid-19 vaccines while Novavax still awaits full FDA ...

Novavax Says Its COVID-19 Shot Is on Track for Full FDA Approval After Delay WASHINGTON (AP) — Novavax's closely watched COVID-19 vaccine is on track for full approval after additional ...

WASHINGTON — Novavax’s closely watched COVID-19 vaccine is on track for full ... vaccine safety. With full FDA approval, Novavax would have permission to keep its shot on the market indefinitely.

Novavax's closely watched COVID-19 vaccine is on track for full approval after ... made by Pfizer and Moderna that have earned full FDA approval for certain age groups.